Tazu P 4000mg/500mg Injection
Marketer
Kadwin Drugs
Salt Composition
Piperacillin (4000mg) + Tazobactum (500mg)
Overview Tazu P 4000mg/500mg Injection
Combiflox 4000mg/500mg Injection is a dual-antibiotic formulation indicated for treating diverse bacterial infections. Its mechanism involves microbial eradication. Administration should always be performed by a qualified medical practitioner; self-injection is strictly prohibited. Dosage and frequency are determined by the physician based on the patient's condition. Adherence to the prescribed regimen is crucial. Commonly reported adverse effects include gastrointestinal upset (nausea, vomiting, diarrhea), skin reactions (rash), and injection site responses (pain, swelling, erythema). Persistent or worsening side effects necessitate immediate medical attention. Prior to treatment, patients should disclose any antibiotic allergies, renal or hepatic impairments to their physician, who may then adjust the dosage or alternative medication. Under medical guidance, this injection is generally considered safe during pregnancy and lactation.
Uses of Tazu P 4000mg/500mg Injection
Infections caused by bacteria
Major Benefits of Tazu P 4000mg/500mg Injection:
The medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
Common Side effects of Tazu P 4000mg/500mg Injection:
- Nausea
- Vomiting
- Diarrhea
- Rash
- Allergic reaction
How to use Tazu P 4000mg/500mg Injection:
This medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
How Tazu P 4000mg/500mg Injection works:
Tazu P Injection, containing 4000mg of piperacillin and 500mg of tazobactam, employs a dual-drug approach to combat bacterial infections. Piperacillin, a potent antibiotic, disrupts bacterial cell wall synthesis, a critical process for bacterial viability. Tazobactam, a beta-lactamase inhibitor, complements piperacillin by counteracting bacterial resistance mechanisms, thereby boosting the antibiotic's effectiveness.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse reactions associated with the concomitant use of alcohol and Tazu P 4000mg/500mg Injection.
PregnancySAFE IF PRESCRIBED
The injectable medication Tazu P (4000mg/500mg) is usually deemed safe for pregnant individuals. Preclinical trials in animals revealed minimal or absent harm to the fetus; nonetheless, data from human trials are scarce.
Breast feedingSAFE IF PRESCRIBED
The injectable medication Tazu P (4000mg/500mg) presents minimal risk during lactation. Research in humans indicates negligible transfer into breast milk, posing no appreciable threat to the infant.
DrivingCONSULT YOUR DOCTOR
The effect of Tazu P 4000mg/500mg Injection on driving ability is unknown. Refrain from driving if you experience symptoms impairing concentration or reaction time.
KidneyCAUTION
Patients with impaired kidney function should receive Tazu P 4000mg/500mg Injection with close monitoring. Dosage modification may be necessary for such patients. Medical advice is recommended.
LiverSAFE IF PRESCRIBED
Tazu P 4000mg/500mg Injection appears to pose minimal risk for individuals with hepatic impairment. Current evidence indicates dose modification of Tazu P 4000mg/500mg Injection may be unnecessary in this population; however, physician consultation is recommended.
What if you forget to take Tazu P 4000mg/500mg Injection :
Omit a dose of Tazu P 4000mg/500mg Injection? Seek your physician's advice.
Facts to Know About Tazu P 4000mg/500mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Treatment | Antimicrobial Agents |
3,018 People bought this recently